Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 2/2014

Content (12 Articles)

editorial

An academic pathological dilemma

Helmut H. Popper

editorial

Follow-up for patients with malignancies after radical treatment: unresolved questions

Vladimir Moiseyenko

short review

Follow-up in aggressive lymphomas

Jan Walewski

Open Access short review

Follow-up in melanoma patients

Piotr Rutkowski, Iwona Ługowska

Open Access short review

Follow-up in patients treated for head and neck cancer

Andrzej Kawecki, Romuald Krajewski

Open Access short review

Follow-up in soft tissue sarcomas

Piotr Rutkowski, Iwona Ługowska

review

Follow-up in non-small-cell lung cancer

Sacha I. Rothschild, Didier Lardinois, Jens Bremerich, Michael Tamm, Lukas Bubendorf, Alexandros Papachristofilou, Hansruedi Stoll, Alfred Zippelius

short review

Follow-up in gastrointestinal cancer

Ulrich Popper, Clemens Dormann, Holger Rumpold

short review

Current therapeutic concepts in mucosa-associated lymphoid tissue (MALT) lymphoma

Barbara Kiesewetter, Markus Raderer

short review

Highlights in the prevention of sporadic colorectal cancer

Andrey Iskrenov Kotzev, Margarita Angelova Kamenova

short review

Treatment results and follow-up after definitive radio-chemotherapy in anal cancer: when to perform biopsies?

Martina Becker-Schiebe, Wolfgang Hoffmann

case report

Activity of nab-paclitaxel in a heavily-pretreated breast cancer patient who experienced a change of tumour biology

Ursula Pluschnig, Hans-Jörg Neumann

Apr 14
Issue: Special Issue 1/2014
Sep 14
Issue: 3/2014

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits